Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Search Product Recalls

Try:····

Filters

Category

All Categories Food Medication Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Time Period

All Time Last 30 Days Last 90 Days Last Year

State

Severity

All Severities Class I (High Risk)Class II (Moderate)Class III (Low)

Source

All Sources FDA CPSC USDA NHTSA

Status

Include terminated recalls

Clear all filters

Showing 1881–1900 of 2326 results

Sort:

Newest first Oldest first

Metformin Hydrochloride Extended-Release Tablets (Amneal) – NDMA Impurity (2020)

CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level

Class IIModerate

FDAMay 29, 2020Nationwide• Amneal Pharmaceuticals of New York, LLC

Metformin Hydrochloride Extended-Release (Amneal) – NDMA Impurity (2020)

CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level

Class IIModerate

FDAMay 29, 2020Nationwide• Amneal Pharmaceuticals of New York, LLC

Metformin Hydrochloride Extended-Release Tablets (Amneal) – NDMA Impurity (2020)

CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level

Class IIModerate

FDAMay 29, 2020Nationwide• Amneal Pharmaceuticals of New York, LLC

Metformin Hydrochloride Extended-Release (Amneal) – NDMA Impurity (2020)

CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level

Class IIModerate

FDAMay 29, 2020Nationwide• Amneal Pharmaceuticals of New York, LLC

Metformin Hydrochloride Extended-Release (Amneal) – NDMA Impurity (2020)

CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level

Class IIModerate

FDAMay 29, 2020Nationwide• Amneal Pharmaceuticals of New York, LLC

Metformin Hydrochloride Extended-Release (Amneal) – NDMA Impurity (2020)

CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level

Class IIModerate

FDAMay 29, 2020Nationwide• Amneal Pharmaceuticals of New York, LLC

Metformin Hydrochloride Extended-Release Tablets (Amneal) – NDMA Impurity (2020)

CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level

Class IIModerate

FDAMay 29, 2020Nationwide• Amneal Pharmaceuticals of New York, LLC

Metformin Hydrochloride Extended-Release Tablets (Amneal) – NDMA Impurity (2020)

CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level

Class IIModerate

FDAMay 29, 2020Nationwide• Amneal Pharmaceuticals of New York, LLC

Metformin Hydrochloride Extended-Release Tablets (Amneal) – NDMA Impurity (2020)

CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level

Class IIModerate

FDAMay 29, 2020Nationwide• Amneal Pharmaceuticals of New York, LLC

Metformin Hydrochloride Extended-Release Tablets (Amneal) – NDMA Impurity (2020)

CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level

Class IIModerate

FDAMay 29, 2020Nationwide• Amneal Pharmaceuticals of New York, LLC

LidoPro Patch (Wuhan Bingbing) – Manufacturing Records Lost (2020)

CGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification through the labeled expiration date.

Class IIModerate

FDAMay 19, 2020Nationwide• Wuhan Bingbing Pharmaceutical Co., Ltd.

LidoPatch (Wuhan Bingbing) – Manufacturing Records Lost (2020)

CGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification through the labeled expiration date.

Class IIModerate

FDAMay 19, 2020Nationwide• Wuhan Bingbing Pharmaceutical Co., Ltd.

Mencaine Patch (Wuhan Bingbing) – Manufacturing Records Lost (2020)

CGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification through the labeled expiration date.

Class IIModerate

FDAMay 19, 2020Nationwide• Wuhan Bingbing Pharmaceutical Co., Ltd.

Lidocaine Cold & Hot Patch (Wuhan Bingbing) – Manufacturing Records Lost (2020)

CGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification through the labeled expiration date.

Class IIModerate

FDAMay 19, 2020Nationwide• Wuhan Bingbing Pharmaceutical Co., Ltd.

Advanced Joint Relief Capsules (Absorb Health) – allergen warning (2020)

The firm was notified by the FDA that they failed to included a shellfish allergen on their ingredient panel.

Class IIModerate

FDAApr 15, 2020AZ, CA, FL +14 more• Absorb Health LLC

Losartan Potassium 25mg Bulk (Teva) – CGMP Impurity Detection (2020)

CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.

Class IIModerate

FDAMar 25, 2020CA, IN• Teva Pharmaceuticals USA

Losartan Potassium 50mg Bulk (Teva) – CGMP Impurity Detection (2020)

CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.

Class IIModerate

FDAMar 25, 2020CA, IN• Teva Pharmaceuticals USA

Losartan Potassium 100mg Bulk (Teva) – CGMP Impurity Detection (2020)

CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.

Class IIModerate

FDAMar 25, 2020CA, IN• Teva Pharmaceuticals USA

Banana Pudding Ice Cream (Hunter Farms) – undeclared soy (2020)

The firm was notified that the product contains undeclared soy.

Class IIModerate

FDAFeb 11, 2020IN, NC• Harris Teeter Supermarkets, LLC dba Hunter Farms

Granulate Pure Cane Sugar (Sugar Foods) – Contamination Risk (2020)

They were notified by their supplier that the product may be contaminated with foreign material.

Class IIModerate

FDAJan 12, 2020AL, AZ, CA +14 more• Sugar Foods Corporation

1...93 949596 97...117

Page 95 of 117Next